DERM vs PG · rev $56.1M vs P/E 25, rev $84.28B
Journey Medical Corp (DERM) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
DERM currently screens at market cap $163.1M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the DERM and PG stock pages for the full models.
Not investment advice.